EXHIBIT 10.2



 


Exhibit
10.2 


 


REGISTRATION RIGHTS AGREEMENT


 


THIS REGISTRATION RIGHTS
AGREEMENT (the “Agreement”) is entered into as of the ____ day of __________, 2014 by and among Vaporin, Inc., a Delaware
corporation (the “Company”), and _______________ (the “Investor”).


 


WHEREAS, the Company issued
shares of its common stock to the Investor in connection with the Securities Purchase Agreement dated the date of this Agreement (the “SPA”); and


 


WHEREAS, the Company has
agreed in the SPA to provide certain registration rights to the Investor.


 


Now, therefore, in consideration
of the mutual promises and the covenants as set forth herein, the parties hereto hereby agree as follows:


 


1.Definitions. Unless
the context otherwise requires, the terms defined in this Section 1 shall have the meanings herein specified for all purposes of
this Agreement, applicable to both the singular and plural forms of any of the terms herein defined.


 


“Agreement”
means this Registration Rights Agreement, as the same may be amended, modified or supplemented in accordance with the terms hereof.


 


“Board”
means the Board of Directors of the Company.


 


“Common Stock”
means the Company’s authorized common stock, as constituted on the date of this Agreement, any stock into which such Common
Stock may thereafter be changed and any stock of the Company of any other class, which is not preferred as to dividends or assets
over any other class of stock of the Company and which is not subject to redemption, issued to the holders of shares of such Common
Stock upon any re-classification thereof.


 


“Commission”
means the Securities and Exchange Commission or any other governmental body at the time administering the Securities Act.


 


“Company”
has the meaning assigned to it in the introductory paragraph of this Agreement.


 


“Company Securities”
has the meaning any securities proposed to be sold by the Company for its own account in a registered public offering.


 


“Exchange Act”
means the Securities Exchange Act of 1934 (or successor statute).


 


“Excluded Forms”
means registration statements under the Securities Act, on Forms S-4 and S-8, or any successors thereto and any form used in connection
with an initial public offering of securities.


 




    	 



    	 



    


 


“Investor”
has the meaning assigned to it in the introductory paragraph of this Agreement.


 


“Other Shares”
has the meaning assigned to it in Section 4(f) of this Agreement.


 


“Person”
includes any natural person, corporation, trust, association, company, partnership, joint venture, limited liability company and
other entity and any government, governmental agency, instrumentality or political subdivision.


 


The terms “register”
“registered” and “registration” refer to a registration effected by preparing and filing
a registration statement on other than any of the Excluded Forms in compliance with the Securities Act, and the declaration or
ordering of the effectiveness of such registration statement.


 


“Registrable Securities”
means the Common Stock received by the Investor under the SPA and any securities of the Company issued with respect to such Common
Stock by way of a stock dividend or stock split or in connection with a combination, recapitalization, share exchange, consolidation
or other reorganization of the Company.


 


“Selling Expenses”
means all selling commissions, finder’s fees and stock transfer taxes applicable to the Registrable Securities registered
by the Investor and all fees and disbursements of counsel for the Investor.


 


“Securities Act”
means the Securities Act of 1933 (or successor statute).


 


“SPA”
has the meaning assigned to it in the first WHEREAS clause.


 


Piggyback Registration.


 


(a)Each time the Company proposes for
any reason to register any of its Common Stock under the Securities Act in connection with the proposed offer and sale of its Common
Stock for money, either for its own account or on behalf of any other security holder (a “Proposed Registration”),
other than pursuant to a registration statement on Excluded Forms, the Company shall promptly give written notice of such Proposed
Registration to the Investors and shall offer the Investors the right to request inclusion of its Registrable Securities in the
Proposed Registration.


 


(b)Each of the Investors shall have
20 days from the receipt of such notice to deliver to the Company a written request specifying the number of Registrable Securities
such Investor intends to sell in the Proposed Registration and the Investor’s intended method of disposition.


 


(c)In the event that the Proposed Registration
by the Company is, in whole or in part, an underwritten public offering, the Company shall so advise the Investor as part of the
written notice given pursuant to Section 2(a), and any request under Section 2(b) must specify that the Investor’s Registrable
Securities be included in the underwriting on the same terms and conditions as the shares of Common Stock, if any, otherwise being
sold through underwriters under such registration.


 




    	2



    	 



    


 


(d)Upon receipt of a written request
pursuant to Section 2(b), the Company shall promptly use commercially reasonable efforts to cause all such Registrable Securities
held by the Investors to be registered under the Securities Act (and included in any related qualifications under blue sky laws
or other compliance), to the extent required to permit sale or disposition as set forth in the Proposed Registration.


 


(e)In the event that the offering is
to be an underwritten offering, if the Investors propose to distribute its Registrable Securities through such underwritten offering,
then the Investors agree to enter into an underwriting agreement with the underwriter or underwriters selected for such underwriting
by the Company.


 


3.Obligations of the Company.
If and whenever the Company is required by the provisions hereof to effect or cause the registration of any Registrable Securities
under the Securities Act as provided herein, the Company shall:


 


(a)use
commercially reasonable efforts to prepare and file with the Commission a registration statement with respect to such Registrable
Securities and use commercially reasonable efforts to cause such registration statement to become and remain effective;


 


(b)use
commercially reasonable efforts to prepare and file with the Commission such amendments to such registration statement (including
post-effective amendments) and supplements to the prospectus included therein as may be necessary to keep such registration statement
effective, subject to the qualifications in Section 4(a), and to comply with the provisions of the Securities Act with respect
to the sale or other disposition of all Registrable Securities covered by such registration statement during such period in accordance
with the intended methods of disposition by the Investor set forth in such registration statement;


 


(c)furnish
to the Investor such number of copies of such registration statement and of each such amendment and supplement thereto (in each
case including all exhibits), such number of copies of the prospectus included in such registration statement (including each preliminary
prospectus), in conformity with the requirements of the Securities Act, and such other documents, as each Investor may reasonably
request, in order to facilitate the public sale or other disposition of the Registrable Securities owned by the Investor;


 


(d)use
all commercially reasonable efforts to make such filings under the securities or blue sky laws of New York to enable the the Investor
to consummate the sale in such jurisdiction of the Registrable Securities owned by the Investor;


 




    	3



    	 



    


 


(e)notify
the Investor at any time when a prospectus relating to their Registrable Securities is required to be delivered under the Securities
Act, of the Company’s becoming aware that the prospectus included in the related registration statement, as then in effect,
includes an untrue statement of a material fact or omits to state any material fact required to be stated therein or necessary
to make the statements therein not misleading in light of the circumstances then existing, and promptly prepare and furnish to
the Investor a reasonable number of copies of a prospectus supplemented or amended so that, as thereafter delivered to the purchasers
of such Registrable Securities, such prospectus shall not include an untrue statement of a material fact or omit to state a material
fact required to be stated therein or necessary to make the statements therein not misleading in the light of the circumstances
then existing;


 


(f)otherwise
use commercially reasonable efforts to comply with all applicable rules and regulations of the Commission;


 


(g)to
use commercially reasonable efforts to cause Registrable Securities to be quoted on each trading market and/or in each quotation
service on which the Common Stock of the Company is then quoted; and


 


(h)notify
the Investor of any stop order threatened or issued by the Commission and take all actions reasonably necessary to prevent the
entry of such stop order or to remove it if entered.


 


4.Other Procedures.


 


(a) Subject to
the remaining provisions of this Section 4(a) and the Company’s general obligation to use commercially reasonable efforts
under Section 3, the Company shall be required to maintain the effectiveness of a registration statement (under Form S-1 or Form
S-3, or successor forms) until the earlier of (i) the sale of all Registrable Securities or (ii) 12 months from the date of this
Agreement. The Company shall have no liability to the Investor for delays in the Investor being able to sell the Registrable Securities
(i) as long as the Company uses commercially reasonable efforts to file a registration statement, amendments to a registration
statement, post-effective amendments to a registration statement or supplements to a prospectus contained in a registration statement
(including any amendment or post effective amendments), (ii) where the required financial statements or auditor’s consents
are unavailable or (iii) where the Company would be required to disclose information at a time when it has no duty to disclose
such information under the Securities Act, the Exchange Act, or the rules and regulations of the Commission.


 


(b)In consideration of the Company’s
obligations under this Agreement, the Investor agrees that, upon receipt of any notice from the Company of the happening of any
event of the kind described in Section 3(e) herein, the Investor shall forthwith discontinue his sale of Registrable Securities
pursuant to the registration statement covering such Registrable Securities until the Investor’s receipt of the copies of
the supplemented or amended prospectus contemplated by said Section 3(e) and, if so directed by the Company, shall deliver
to the Company (at the Company’s expense) all copies, other than permanent file copies, then in the Investor’s possession
of the prospectus covering such Registrable Securities current at the time of receipt of such notice. Furthermore, during any calendar
year, the Company may for any reason suspend the effectiveness of the registration statement for up to 30 days for any reason or
no reason; however such period of suspension shall be added to the 12 month period set forth in Section 4(a).


 




    	4



    	 



    


 


(c) The Company’s obligation to file
any registration statement or amendment including a post-effective amendment, shall be subject to each Investor, as applicable,
furnishing to the Company in writing such information and documents regarding such Investor and the distribution of such Investor’s
Registrable Securities as may reasonably be required to be disclosed in the registration statement in question by the rules and
regulations under the Securities Act or under any other applicable securities or blue sky laws of the jurisdiction referred to
in Section 3(d) herein. The Company’s obligations are also subject to each Investor promptly executing any representation
letter concerning compliance with Regulation M under the Exchange Act (or any successor rule or regulation).


 


(d)If any such
registration or comparable statement refers to the Investor by name or otherwise as a stockholder of the Company, but such reference
to the Investor by name or otherwise is not required by the Securities Act or the rules thereunder, then each Investor shall have
the right to require the deletion of the reference to the Investor, as may be applicable.


 


(e)In connection with the sale of Registrable
Securities, the Investor shall deliver to each purchaser a copy of the necessary prospectus and, if applicable, prospectus supplement,
within the time required by Section 5(b) of the Securities Act.


 


5.Registration
Expenses. In connection with any registration of Registrable Securities pursuant to Section
2, the Company shall, whether or not any such registration shall become effective, from time to time, pay all expenses (other than
Selling Expenses) incident to its performance of or compliance, including, without limitation, all registration, and filing fees,
fees and expenses of compliance with securities or blue sky laws, word processing, printing and copying expenses, messenger and
delivery expenses, fees and disbursements of counsel for the Company and all independent public accountants and other Persons retained
by the Company.


 


6.Indemnification.


 


(a)In the event of any registration
of any shares of Common Stock under the Securities Act pursuant to this Agreement, the Company shall indemnify and hold harmless
each Investor, from and against any losses, claims, damages or liabilities, joint or several, to which each Investor may become
subject under the Securities Act or otherwise, insofar as such losses, claims, damages or liabilities (or actions in respect thereof)
arise out of or are based upon an untrue statement or alleged untrue statement of a material fact contained in any registration
statement under which such Registrable Securities were registered under the Securities Act, any preliminary prospectus or final
prospectus contained therein, or any amendment or supplement thereto, or any document incident to registration or qualification
of any Registrable Securities pursuant to Section 3(d) herein, or arise out of or are based upon the omission or alleged omission
to state therein a material fact required to be stated therein or necessary to make the statements therein not misleading or, with
respect to any prospectus, necessary to make the statements therein, in light of the circumstances under which they were made,
not misleading, or any violation by the Company of the Securities Act, the Exchange Act, or state securities or blue sky laws applicable
to the Company and relating to action or inaction required of the Company in connection with such registration or qualification
under the Securities Act or such state securities or blue sky laws. If the Company fails to defend the Investor as required by
Section 6(c) herein, it shall reimburse (after receipt of appropriate documentation) each Investor for any legal or any other out-of-pocket
expenses reasonably incurred by any of them in connection with investigating or defending any such loss, claim, damage, liability
or action; provided, however, that the Company shall not be liable to an Investor in any such case to the extent that any
such loss, claim, damage or liability arises out of or is based upon (i) an untrue statement or alleged untrue statement or omission
or alleged omission made in said registration statement, said preliminary prospectus, said prospectus, or said amendment or supplement
or any document incident to registration or qualification of any Registrable Securities pursuant to Section 3(d) hereof in reliance
upon and in conformity with written information furnished to the Company by such Investor specifically for use in the preparation
thereof or information omitted to be furnished by such Investor or (ii) any act or failure to act of such Investor including the
failure of any Investor to deliver a prospectus as required by Section 5(b) of the Securities Act.


 




    	5



    	 



    


 


(b)In the event of any registration
of any Registrable Securities under the Securities Act pursuant to this Agreement, each Investor shall indemnify and hold harmless
(in the same manner and to the same extent as set forth in Section 6(a)) the Company, each director of the Company, each officer
of the Company who signs such registration statement, the Company’s attorneys and auditors and any Person who controls the
Company within the meaning of the Securities Act, with respect to (i) any untrue statement or omission from such registration statement,
any preliminary prospectus or final prospectus contained therein, or any amendment or supplement thereto, if such untrue statement
or omission was made in reliance upon and in conformity with written information furnished to the Company by such Investor specifically
for use in the preparation of such registration statement, preliminary prospectus, final prospectus or amendment or supplement
or (ii) from any other act or failure to act of the Investor.


 


(c)Promptly after receipt by an indemnified
party of notice of the commencement of any action involving a claim referred to in Section 6(a) or (b), such indemnified party
shall, if a claim in respect thereof is made against an indemnifying party, give written notice to the Indemnifying Party of the
commencement of such action. The indemnifying party shall be relieved of its obligations under this Section 6(c) to the extent
that the indemnified party delays in giving notice and the indemnifying party is damaged or prejudiced by the delay. In case any
such action is brought against an indemnified party, the indemnifying party shall be entitled to participate in and to assume the
defense thereof, jointly with any other indemnifying party similarly notified to the extent that it may wish, with counsel reasonably
satisfactory to such indemnified party, and, after notice from the indemnifying party to such indemnified party of its election
so as to assume the defense thereof, the indemnifying party shall be responsible for any legal or other expenses subsequently incurred
by the indemnifying party in connection with the defense thereof, provided, however, that, if counsel for an indemnified
party shall have reasonably concluded that there is an actual or potential conflict of interest between the indemnified and the
indemnifying party the indemnifying party shall not have the right to assume the defense of such action on behalf of such indemnified
party, and such indemnifying party shall reimburse such indemnified party and any Person controlling such indemnified party for
the fees and expenses of counsel retained by the indemnified party which are reasonably related to the matters covered by the indemnity
agreement provided in this Section 6; provided, however, that in no event shall any indemnification by an Investor under
this Section 6 exceed the net proceeds from the sale of Registered Securities received by the Investor. No indemnified party shall
make any settlement of any claims indemnified against hereunder without the written consent of the indemnifying party, which consent
shall not be unreasonably withheld. In the event that any indemnifying party enters into any settlement without the written consent
of the indemnified party the indemnifying party shall not, consent to entry of any judgment or enter into any settlement which
does not include as an unconditional term thereof the giving by the claimant or plaintiff of a release of such indemnified party
from all liability in respect to such claim or litigation.


 




    	6



    	 



    


 


(d)In order to provide for just and
equitable contribution to joint liability under the Securities Act in any case in which under any indemnified party makes a claim
for indemnification pursuant to this Section 6, but it is judicially determined (by the entry of a final judgment or decree by
a court of competent jurisdiction and the expiration of time to appeal or the denial of the last right of appeal) that such indemnification
may not be enforced in such case notwithstanding the fact that this Section 6 provides for indemnification in such case, or (ii)
contribution under the Securities Act may be required in circumstances for which indemnification is provided under this Section
6; then, in each such case, the Company and such Investor shall contribute to the aggregate losses, claims, damages or liabilities
to which they may be subject as is appropriate to reflect the relative fault of the Company and such Investor in connection with
the statements or omissions which resulted in such losses, claims, damages or liabilities, it being understood that the parties
acknowledge that the overriding equitable consideration to be given effect in connection with this provision is the ability of
one party or the other to correct the statement or omission (or avoid the conduct or take an act) which resulted in such losses,
claims, damages or liabilities, and that it would not be just and equitable if contribution pursuant hereto were to be determined
by pro-rata allocation or by any other method of allocation which does not take into consideration the foregoing equitable considerations.
Notwithstanding the foregoing, (i) no such Investor shall be required to contribute any amount in excess of the net proceeds to
him of all Registrable Securities sold by him pursuant to such registration statement, and (ii) no Person who is guilty of fraudulent
misrepresentation within the meaning of Section 11(f) of the Securities Act shall be entitled to contribution from any Person who
is not guilty of such fraudulent misrepresentation.


 


(e)Notwithstanding any of the foregoing,
if, in connection with an underwritten public offering of the Registrable Securities, the Company, any of the Investor and the
underwriters enter into an underwriting agreement relating to such offering which contains provisions covering indemnification
among the parties, then the indemnification provision of this Section 6 shall be deemed inoperative for purposes of such offering.


 


(f)Following indemnification as provided
for under this Agreement, the indemnifying party shall be subrogated to all rights of the Indemnified Party or Indemnified Person
with respect to all third parties, firms or corporations relating to the matter for which indemnification has been made.


 




    	7



    	 



    


 


7.Certain Limitations on Registration
Rights. At any time prior to the effectiveness of any registration statement filed pursuant to this Agreement, if
the Company determines to file a registration statement with the Commission for the public sale of its securities and the managing
underwriter of such offering offers to purchase the Registrable Securities for its own account at the same price including underwriting
discounts and applicable expenses as paid to the Company, the Investor shall either (i) elect to include their Registrable Securities
being registered pursuant to this Agreement in the registration statement covering the sale of the Company’s securities,
or (ii) immediately cease their public sales for a period of 90 days following the effective date of the registration statement
covering the sale by the Company. Additionally, no Investor may participate in the registration statement relating to the sale
by the Company of its Common Stock as provided above unless such Investor enters into an underwriting agreement with the managing
underwriter and completes and/or executes all questionnaires, indemnities and other reasonable documents requested by the managing
underwriter. Each Investor shall be deemed to have agreed by acquisition of its Registrable Securities not to effect any public
sale or distribution, including any sale pursuant to Rule 144 under the Securities Act, of any Registrable Securities and to use
its best efforts not to effect any such public sale or distribution of any other equity security of the Company (including any
short sale) or of any security convertible into or exchangeable or exercisable for any equity security of the Company (other than
as part of such underwritten public offering) within 10 days before or 90 days after the effective date of such registration statement.
In such event, the Investor shall, if requested, sign a customary market stand-off letter with the Company’s managing underwriter,
and to comply with applicable rules and regulations of the Commission.


 


8.Allocation of Securities Included
in Registration Statement. In the case of a registration pursuant to Section 7 for the Company’s account,
if the Company’s managing underwriter shall advise the Company and the Investor in writing that the inclusion in any registration
pursuant hereto of some or all of (a) the Registrable Securities sought to be registered by the Investor and securities offered
by other holders, and (b) the Company’s securities sought to be registered creates a substantial risk that the proceeds or
price per unit that will be derived from such registration will be reduced or that the number of securities to be registered is
too large a number to be reasonably sold, (i) first, the number of Company securities sought to be registered shall be included
in such registration, and (ii) next, the number of Registrable Securities offered by the Investor and securities offered by other
holders shall be included in such registration to the extent permitted by the Company’s managing underwriter with the number
of Registrable Securities and such other securities being registered determined on a pro-rata basis based on the number of Registered
Securities and securities the participating holders including the Investor desire to have registered; provided, however,
that, if any participating Investor would be required pursuant to the provisions of this Section 7 to reduce the number of Registrable
Securities that he may include in such registration, the Investor may withdraw all or any portion of its Registrable Securities
from such registration and may resume selling shares under the registration statement (assuming it is effective) referred to in
Section 2 after the 90-day lock-up period.


 




    	8



    	 



    


 


9.Rule 144. The Company
covenants that it will file the reports required to be filed under the Securities Act and the Exchange Act and the rules and regulations
adopted by the Commission thereunder (or, in the event that the Company is not required to file such reports, it will make publicly
available information as set forth in Rule 144(c)(2) promulgated under the Securities Act), and it will take such further action
as the Investor may reasonably request, or to the extent required from time to time to enable the Investor to sell their Registrable
Securities without registration under the Securities Act within the limitation of the exemption provided by (a) Rule 144 under
the Securities Act, as such Rule may be amended from time to time, or (b) any similar rule or regulation hereafter adopted by the
Commission (collectively, “Rule 144”). Upon request of any Investor, the Company will deliver to the Investor a written
statement as to whether it has complied with such requirements.


 


11.Severability. In the
event any parts of this Agreement are found to be void, the remaining provisions of this Agreement shall nevertheless be binding
with the same effect as though the void parts were deleted.


 


12.Counterparts. This
Agreement may be executed in one or more counterparts, each of which shall be deemed an original but all of which together shall
constitute one and the same instrument. The execution of this Agreement may be by actual or facsimile signature.


 


13.Benefit. This Agreement
shall be binding upon and inure to the benefit of the parties hereto and their legal representatives, successors and assigns.


 


14.Notices and Addresses.
All notices, offers, acceptance and any other acts under this Agreement (except payment) shall be in writing, and shall be sufficiently
given if delivered to the addressees in person, by Federal Express or similar overnight next business day delivery, or by email
delivery followed by overnight next business day delivery, as follows:


 


	To the Company:	Vaporin, Inc. 
	 	4400 Biscayne Blvd.
	 	Suite 850
	 	Miami, FL 33137
	 	Email: Scott@vaporin.com
	 	_____________________________
	 	_____________________________
	 	_____________________________
	 	_____________________________


 


	With a Copy to:	Michael D. Harris, Esq.
	 	Nason, Yeager, Gerson, White & Lioce, P.A.
	 	1645 Palm Beach Lakes Blvd.
	 	12th Floor
	 	West Palm Beach, FL 33401


 




    	9



    	 



    


 


To the Investor__________________At
the address set foirth on the signature page to the SPA or to such other address as any of them, by notice to the other may
designate from time to time. Time shall be counted from the date of delivery.


 


15.Attorneys’ Fees.
In the event that there is any controversy or claim arising out of or relating to this Agreement, or to the interpretation, breach
or enforcement thereof, and any action or proceeding relating to this Agreement is filed, the prevailing party shall be entitled
to an award by the court of reasonable attorneys’ fees, costs and expenses.


 


16.Oral Evidence. This
Agreement constitutes the entire Agreement between the parties and supersedes all prior oral and written agreements between the
parties hereto with respect to the subject matter hereof. Neither this Agreement nor any provision hereof may be changed, waived,
discharged or terminated orally, except by a statement in writing signed by the party or parties against which enforcement or the
change, waiver discharge or termination is sought.


 


17.Additional Documents.
The parties hereto shall execute such additional instruments as may be reasonably required by their counsel in order to carry out
the purpose and intent of this Agreement and to fulfill the obligations of the parties hereunder.


 


18.Governing Law. This
Agreement and any dispute, disagreement, or issue of construction or interpretation arising hereunder whether relating to its execution,
its validity, the obligations provided herein or performance shall be governed or interpreted according to the internal laws of
the State of Delaware without regard to choice of law considerations.


 


19.Arbitration. Any controversy,
dispute or claim arising out of or relating to this Agreement, or its interpretation, application, implementation, breach or enforcement
which the parties are unable to resolve by mutual agreement, shall be settled by submission by either party of the controversy,
claim or dispute to binding arbitration in Miami, Florida (unless the parties agree in writing to a different location), before
a single arbitrator in accordance with the rules of the American Arbitration Association then in effect. In any such arbitration
proceeding the parties agree to provide all discovery deemed necessary by the arbitrator. The decision and award made by the arbitrator
shall be final, binding and conclusive on all parties hereto for all purposes, and judgment may be entered thereon in any court
having jurisdiction thereof.


 


20.Section or Paragraph Headings.
Section headings herein have been inserted for reference only and shall not be deemed to limit or otherwise affect, in any matter,
or be deemed to interpret in whole or in part any of the terms or provisions of this Agreement.


 


21.Force Majure. The
Company shall be excused from any delay in performance or for non-performance of any of the terms and conditions of this Agreement
caused by any circumstances beyond its control, including, but not limited to, any Act of God, fire, flood, or government regulation,
direction or request, or accident, interruption of telecommunications facilities, labor dispute, unavoidable breakdown, terrorist
event or civil unrest or disruption to the extent that any of such circumstances affect the Company’s ability to perform
its obligations under this Agreement or the ability of the Commission to perform its responsibilities under the Securities Act.


 


[Remainder of this page intentionally left blank.]


 




    	10



    	 



    


 


IN WITNESS WHEREOF, each
of the parties hereto has caused this Agreement to be executed personally or by a duly authorized representative thereof as of
the day and year first above written.


 


	 	THE COMPANY:
	 	 	 
	 	[VAPORIN, INC.]
	 	 	 
	 	By:	 
	 	 	Scott Frohman, CEO
	 	 	 
	 	INVESTOR:
	 	 	 
	 	 	 
	 	Signature


 



    	11